Skip to main content
. 2020 Apr 7;21(7):2559. doi: 10.3390/ijms21072559

Figure 4.

Figure 4

Src activity is partially responsible for the dysregulation of PLEKHA7 and RNAi components in colon cancer cells. HT-29, DLD-1, and LS174T colon cancer cells were treated with the Src inhibitor PP2 or DMSO vehicle (control) for 24 h and: (AC) stained by immunofluorescence for PLEKHA7, p120, DROSHA, Ago2 and imaged by confocal microscopy (scale bars: 20 μM); (D,E) subjected to western blot for the markers shown. Actin is the loading control.